SEC Form 4 · accession 0000899243-15-010027
vTv Therapeutics Inc. · VTVT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry Douglas Altstiel
Officer — Chief Medical Officer
Period of report
Dec 16, 2015
Accepted (ET)
Dec 17, 2015 · 3:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641489
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $6.47 | Dec 16, 2015 | A | 140,000 | A | — | Dec 16, 2025 | Class A common stock | 140,000 | 140,000 | D |
Explanation of responses
- F1The option vests in three equal annual installments beginning on December 16, 2016.